Sanis Health Inc. Ranitidine Product Recall (2019-09-24)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
| Lot or serial number | Brand name | Companies | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| All lots | B. Ranitidine | - Recalling Firm
- Sanis Health Inc.
- 1 President’s Choice Circle,
- Brampton
- L6Y 5S5
- Ontario
- CANADA
- Marketing Authorization Holder
- Sanis Health Inc.
- 1 President’s Choice Circle,
- Brampton
- L6Y 5S5
- Ontario
- CANADA
| DIN 02353024 | Tablet | Ranitidine hydrochloride 300mg |
| All lots | A. Ranitidine | - Recalling Firm
- Sanis Health Inc.
- 1 President’s Choice Circle,
- Brampton
- L6Y 5S5
- Ontario
- CANADA
- Marketing Authorization Holder
- Sanis Health Inc.
- 1 President’s Choice Circle,
- Brampton
- L6Y 5S5
- Ontario
- CANADA
| DIN 02353016 | Tablet | Ranitidine hydrochloride 150mg |
A. Ranitidine
B. Ranitidine
Affected lots may be manufactured with an API containing an impurity, N-nitrosodimethylamine (NDMA).
Wholesalers, Healthcare Establishments, Retailers